AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
66 hedge funds and large institutions have $30.5M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $40.6M → $30.5M (-$10.1M)
Holders
66
Holding in Top 10
1
Calls
$246K
Puts
$143K
Top Buyers
| 1 | +$3.81M | |
| 2 | +$362K | |
| 3 | +$129K | |
| 4 |
FM
Family Management
New York
|
+$98.3K |
| 5 |
Millennium Management
New York
|
+$79K |
Top Sellers
| 1 | -$224K | |
| 2 | -$158K | |
| 3 | -$114K | |
| 4 |
Citigroup
New York
|
-$83.7K |
| 5 |
Squarepoint
New York
|
-$72K |